Clinical Trials in Detroit

Showing 17781-17800 of 19,719 trials

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

NCT00004024

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of biological therapy following surgery and radiation therapy in treating patients who have primary or recurrent astrocytoma or oligodendroglioma.

Brain and Central Nervous System Tumors

Barbara Ann Karmanos Cancer Institute60 participantsStarted Jun 1997

Detroit, Michigan, United States

COMPLETEDPhase 1< 1 mile

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00016185

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining flavopiridol and docetaxel in treating patients who have advanced solid tumors.

Unspecified Adult Solid Tumor, Protocol Specific

Barbara Ann Karmanos Cancer InstituteStarted Mar 2001

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

NCT00003220

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.

Colorectal Cancer

Barbara Ann Karmanos Cancer InstituteStarted Feb 1998

Detroit, Michigan, United States • Detroit, Michigan, United States

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

Find Trials by Condition in Detroit

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Secondary Prevention of Small Subcortical Strokes Trial

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis

Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study